Čájehuvvojit 1 - 4 oktiibuot 4 bohtosis ohcui Chongyu Su', ohcanáigi: 0,04s
Aiddostahte ozu
-
1
Pathologic response and safety to neoadjuvant PD-1 inhibitors and chemotherapy in resectable squamous non-small-cell Lung cancer Dahkki Liang Shi, Qiyi Meng, Li Tong, Hongxia Li, Yujie Dong, Chongyu Su, Zhe Liu
Almmustuhtton 2022-10-01
Artihkal -
2
Copy number variation in plasma as a tool for lung cancer prediction using Extreme Gradient Boosting (XGBoost) classifier Dahkki Daping Yu, Zhidong Liu, Chongyu Su, Yi Han, XinChun Duan, Rui Zhang, Xiaoshuang Liu, Yang Yang, Shaofa Xu
Almmustuhtton 2020-01-01
Artihkal -
3
Preliminary Efficacy Evaluation of Neoadjuvant Immunotherapy Combined with Chemotherapy in Resectable Non-small Cell Lung Cancer Dahkki Shijie ZHOU, Xuefeng HAO, Daping YU, Shuku LIU, Xiaoqing CAO, Chongyu SU, Xiaoyun SONG, Ning XIAO, Yunsong LI, Wei YANG, Dan ZHAO, Jinghui WANG, Zhidong LIU, Shaofa XU
Almmustuhtton 2021-06-01
Artihkal -
4
Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells Dahkki Na Zhu, Wenling Wang, Zhidong Liu, Chaoyang Liang, Wen Wang, Fei Ye, Baoying Huang, Li Zhao, Huijuan Wang, Weimin Zhou, Yao Deng, Longfei Mao, Chongyu Su, Guangliang Qiang, Taijiao Jiang, Jincun Zhao, Guizhen Wu, Jingdong Song, Wenjie Tan
Almmustuhtton 2020-08-01
Artihkal